Fluid Management for Cesarean Section II (FMCS-II)
Fluid Management for Cesarean Section Undergoing Spinal Anesthesia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210004
- The Affiliated Nanjing Maternity and Child Health Care Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 21-40 yr
- First time of delivery
- ASA status I-II
- No premature
- No genetic and infectious diseases
- Chinese
Exclusion Criteria:
- < 21 yr
- > 40 yr
- Subjects with cardiac and pulmonary disorders
- Dislocation of placenta
- Pregnant hypertension
- Allergy to local anesthetics
- Unwilling to cooperation
- Need intraoperative administration of vascular active agents
- With significant delivery side effects
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Prior crystalloid
Crystalloid (Ringer's Lactate) was given before spinal anesthesia
|
Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section
Other Names:
|
|
Active Comparator: Posterior crystalloid
Crystalloid (Ringer's Lactate) was given after spinal anesthesia
|
Ringer's Lactate 8 ml/kg was given intravenously before or after spinal anesthesia in cesarean section
Other Names:
|
|
Active Comparator: Prior colloid
Colloid (6% hydroxyethyl starch) was given before spinal anesthesia
|
Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section
Other Names:
|
|
Active Comparator: Posterior colloid
Colloid (6% hydroxyethyl starch) was given after spinal anesthesia
|
Hydroxyethyl starch (6%) was given before or after spinal anesthesia in cesarean section
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of hypotension
Time Frame: Anesthesia begin (0 min) to 120 min after anesthesia
|
Anesthesia begin (0 min) to 120 min after anesthesia
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Recurrence of hypotension after ephedrine or phenylephrine
Time Frame: Anesthesia begin (0 min) to 120 min after anesthesia
|
Anesthesia begin (0 min) to 120 min after anesthesia
|
|
Consumption of ephedrine and phenylephrine
Time Frame: Anesthesia begin (0 min) to 120 min after anesthesia
|
Anesthesia begin (0 min) to 120 min after anesthesia
|
|
Total volume of colloid or crystalloid
Time Frame: Fifteen minutes before anesthesia to 120 min after anesthesia
|
Fifteen minutes before anesthesia to 120 min after anesthesia
|
|
One-min and 5-min Apgar scores
Time Frame: The first and fifth minute after cesarean successful delivery
|
The first and fifth minute after cesarean successful delivery
|
|
Oxygen saturation during hypotension
Time Frame: Anesthesia begin (0 min) to 120 min after anesthesia
|
Anesthesia begin (0 min) to 120 min after anesthesia
|
|
Duration of hypotension
Time Frame: Anesthesia begin (0 min) to 120 min after anesthesia
|
Anesthesia begin (0 min) to 120 min after anesthesia
|
|
Low umbilical cord pH (artery < 7.20)
Time Frame: At the time of successful delivery (0 min)
|
At the time of successful delivery (0 min)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- NJMU-08711MZ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.